These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date Terminated 2008-008689-11 Efficacy and safety of omega – 3 based lipid solution (Omegaven) in comparison with Lipofundin LCT/MCT in reducing cholestasis in children on parenteral nutrition – randomized double – blind clinical ... bad-data
Ongoing 2013-005528-40 Long-term, prospective study evaluating clinical and molecular biomarkers of epileptogenesis in a genetic model of epilepsy – Tuberous Sclerosis Complex. Een lange-termijn, prospectieve studie om k... not-yet-due
No trial status on register 2020-003231-19 Randomized, double-blind clinical trial of the efficacy and safety of rapamycin versus vigabatrin for the preventive treatment in infants with Tuberous Sclerosis Complex Randomizowane, podwójnie za... bad-data
Ongoing 2021-000580-78 "The assessment of effectiveness and safeness of utilizing empagliflozin in the treatment of neutropenia of patients suffering from glycogenolysis type Ib" „Ocena skuteczności i bezpieczeństwa emp... not-yet-due
Ongoing 2021-001375-16 DIPGEN – Multicenter, open label study using molecularly determined targeted therapies in children 3-18 years of age with DIPG (diffuse intrinsic pontine glioma- DIPG) Zastosowanie terapii celowane... not-yet-due
No trial status on register 2021-004548-64 Multicenter, randomized, double-blind, placebo controlled study to assess the efficacy and safety of Rapamycin in drug Resistant Epilepsy associated with TSC (RaRE-TS) Wieloośrodkowe, randomizowan... bad-data
No trial status on register 2021-006689-18 An open randomized phase II clinical trial evaluating the safety and efficacy of rapamycin in the treatment of gliomas high-grade malignant gliomas in children as part of the establishment management ... bad-data
No trial status on register 2021-006702-78 Open, randomized, IInd phase clinical study evaluating the safety and efficacy of rapamycin in the treatment of drug-resistant epilepsy in children with rare and ultra-rare diseases of the central ner... bad-data